Items where authors include "Cortes, J."
Article
Schmid, P., Zaiss, M., Harper-Wynne, C. et al. (29 more authors) (2019) Fulvestrant plus vistusertib vs fulvestrant plus everolimus vs fulvestrant alone for women with hormone receptor–positive metastatic breast cancer: the MANTA phase 2 randomized clinical trial. JAMA Oncology, 5 (11). pp. 1556-1564. ISSN 2374-2445
Yardley, D.A., Brufsky, A., Coleman, R.E. orcid.org/0000-0002-4275-1043 et al. (10 more authors) (2016) Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial (vol 16, pg 575, 2015). TRIALS, 17. p. 63. ISSN 1745-6215
Yardley, D.A., Brufsky, A., Coleman, R.E. orcid.org/0000-0002-4275-1043 et al. (10 more authors) (2015) Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial. Trials, 16. 575. ISSN 1745-6215
Proceedings Paper
Lee, M., Baird, A.-M., Brown, S. et al. (17 more authors) (2023) The evolving value assessment of cancer therapies: Principles from the cancer community. In: Journal of Clinical Oncology. 2023 ASCO Annual Meeting I, 02-06 Jun 2023, Chicago, IL. American Society of Clinical Oncology , Alexandria, Virginia, USA .